Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednicarbate cream and ointment versus placebo in active atopic dermatitis
2009-012028-98Phase 2Completed
- Sponsor
- GALENpharma GmbH
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of prednicarbate in atopic dermatitis (AD) (2 arms), sponsored by GALENpharma GmbH. Primary endpoint: Safety and local tolerability. Started May 2009; status: completed.
02
Drugs
prednicarbate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2009-012028-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012028-98.